OIS Index Six-Month Review

Michael Lachman, president of EyeQ Research, delivers an update regarding the OIS Index. Given some of the disappointing clinical news in recent months, it’s no surprise the index has underperformed most benchmark indices, but Lachman offers some reason for optimism going forward.